The Hospice Industry Is Entering a New Era of Regulatory Oversight

Recent developments from the Centers for Medicare & Medicaid Services (CMS) suggest that the regulatory environment surrounding hospice care is entering a new phase. Programs such as the Provisional Period of Enhanced Oversight (PPEO) and Expanded Prepayment Review (EPR) are being expanded into additional states, including Georgia and Ohio. This expansion reflects CMS’s continued focus on program integrity within the hospice benefit.

While these initiatives may appear technical on the surface, they signal something much broader for hospice providers across the country.

They signal a shift toward more proactive regulatory oversight, where documentation defensibility, eligibility clarity, and operational transparency will increasingly determine a provider’s stability within the Medicare program.

A Clear Signal From CMS

In a recent analysis, healthcare attorney Bryan Nowicki outlined the implications of CMS expanding PPEO and EPR enforcement efforts. These programs can result in significant operational consequences for hospice organizations. Potential outcomes include 100 percent prepayment review of claims, termination of Medicare enrollment, or revocation of billing privileges if error rates exceed certain thresholds.

These measures are not entirely new. CMS has deployed similar oversight programs in other regions in recent years. Legal and compliance experts have noted that these initiatives reflect a broader enforcement trend across the hospice industry.

For hospice providers, this means the traditional model of retrospective compliance review, which often relies on audits or denial patterns after claims have been submitted, may no longer be sufficient.

The Operational Challenge

Most hospice organizations share a deep commitment to ethical care delivery and regulatory compliance. The challenge facing many providers is not intent or dedication. The challenge is complexity.

Hospice leaders must navigate a regulatory framework that includes Conditions of Participation, Local Coverage Determinations, evolving documentation standards, and multiple layers of audit oversight from entities such as Medicare Administrative Contractors and program integrity contractors.

At the same time, clinicians and operational teams remain focused on delivering compassionate end of life care to patients and families.

The tools many organizations rely on today, including electronic medical records, retrospective audits, and manual chart review processes, were not originally designed to proactively identify documentation vulnerabilities or eligibility risks before claims are submitted or regulatory scrutiny begins.

As oversight expands, the gap between regulatory expectations and operational infrastructure becomes increasingly visible.

The Role of Data and Intelligent Systems

Advances in artificial intelligence and data science may offer new opportunities to support hospice operations in a more proactive way.

When thoughtfully applied, these technologies can help organizations better understand patterns within their own clinical documentation. They can also help identify potential eligibility risks earlier and surface operational signals that might otherwise go unnoticed until a claim denial or audit occurs.

Importantly, these tools should not replace the expertise of clinicians, compliance officers, or medical directors. Their professional judgment remains central to the practice of hospice medicine.

Instead, technology can serve as an additional layer of insight. It can help organizations strengthen documentation practices, support clinical teams, and improve the defensibility of care decisions in an increasingly complex regulatory environment.

Building New Tools for a Changing Landscape

Last year we launched 1520ai, a technology startup focused on exploring how artificial intelligence might be applied responsibly within the hospice industry.

Over the past six months, our team has been working with experienced hospice clinicians, compliance professionals, and data scientists to begin developing tools designed to help organizations better understand documentation patterns, identify potential compliance risks earlier, and strengthen operational visibility.

Our goal is not to replace existing systems or expertise. Our goal is to complement them by providing hospice leaders and clinicians with additional insight into the signals that matter most in a highly regulated environment.

A Turning Point for Hospice Operations

Programs like PPEO and Expanded Prepayment Review should not be viewed solely as regulatory pressure. They also indicate that the infrastructure supporting hospice care must continue to evolve.

Hospice has always been grounded in compassion, dignity, and trust. As oversight becomes more sophisticated, the systems supporting hospice providers must become more sophisticated as well.

If applied thoughtfully, technology can help ensure that hospice organizations remain both clinically strong and operationally resilient in the years ahead.

References

Bryan Nowicki. CMS Expands PPEO and EPR to Georgia and Ohio. Healthcare Law Insights.
https://www.healthcarelawinsights.com/2026/01/cms-expands-ppeo-and-epr-to-georgia-and-ohio/

Bryan Nowicki and Meg Pekarske. Hospice Insights Podcast: Upping the Ante on Hospice Oversight. JD Supra.
https://www.jdsupra.com/legalnews/hospice-insights-podcast-upping-the-an-54662/

By: Ernesto Lopez, MBA, RN, FACHE.

The hospice industry is moving toward an environment where defensibility of care decisions matters as much as the care itself.

The tools used by many hospice organizations today were designed for documentation storage, not documentation intelligence.

Artificial intelligence should not replace the expertise of hospice professionals. It should strengthen the systems that support their work.